Dumping Syndrome Market Research Report - Forecast till 2027

Dumping Syndrome Market Research Report: By Diagnosis (Blood Sugar Test, Gastric Emptying Test, Medical History), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories, Diagnostic Centers) – Forecast till 2027

ID: MRFR/MED/3879-HCR | | Region: Global | 115 pages

Dumping Syndrome Market Scenario


Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping syndrome occurs after gastric bypass surgery. According to the University of Rochester Medical Center, the dumping syndrome can happen in at least 3 out of 20 patients who have had a part of their stomach removed for any reason.


Mostly, people with dumping syndrome develop signs and symptoms, such as abdominal cramps and diarrhea, 10 to 30 minutes after eating. Whereas in some cases people have symptoms one to three hours after eating, few have also reported having both early and late symptoms. Early signs and symptoms include nausea, vomiting, abdominal cramps, diarrhea flushing, dizziness, lightheadedness, and rapid heart rate whereas, late signs and symptoms include sweating, hunger, fatigue, dizziness, lightheadedness, weakness, and rapid heart rate. The rising prevalence of upper GI diseases, changing lifestyle, and increasing demand for minimally invasive surgery are major drivers for the growth of the market across the globe. Additionally, use of technologically advanced devices for a surgical procedure in healthcare institutes also influence the market growth during the forecast period. Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. On the other hand, side effects of dumping syndrome may hamper the market growth during the forecast period.


Th Dumping Syndrome Market is expected to grow at a CAGR of ~6.4 % during the forecast period, 2017-2023.

Figure: Global Dumping Syndrome Market, By Region Market Share, 2016 (%) Dumping Syndrome Market


Sources: Annual reports, Press release, White paper, Company presentation


Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Segmentations


The dumping syndrome market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of diagnosis, dumping syndrome market is segmented into blood sugar test, gastric emptying test, medical history, and others.


Based on the treatment, dumping syndrome market is segmented into medication, surgery, and others. Medication is further sub-segmented into imodium, lomotil, prevalite, colestid, welchol, octreotide, and others.


On the basis of the end user, dumping syndrome market is segmented into hospitals & clinics, research laboratories, and others.


Key Players


Some of key the players in the dumping syndrome market are Medtronic (U.S.), Intuitive Surgical Inc. (U.S.), TransEnterix Inc.  (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Mediflex Surgical Product (U.S.), and others.


Research Methodology
Dumping Syndrome Market 2018


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Americas dominate the dumping syndrome market owing to increasing research & development activities and concentration of major market players boosting the market growth during the forecast period. Moreover, well-developed technology, increasing patient population with upper GI diseases, high healthcare spending, and increasing government support for research & development drive the market growth.


Europe holds the second position in the dumping syndrome market owing to the government support for research & development and availability of funds for research. For instance, countries like Germany and France are increasing investment in the healthcare domain. Furthermore, this is expected to continue to drive the European market over the forecasted period.      


Asia Pacific is the fastest growing dumping syndrome market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for gastrointestinal diseases in countries like India and China is likely to emerge as the fastest growing market across the globe. Moreover, increasing demand for quality devices in the healthcare sector is projected to lead to the use of advanced equipment, which in turn, is anticipated to increase the market growth in the region.   


On the other hand, in the Middle East and Africa, limited market share due to gastrointestinal diseases have become a huge problem owing to limited screening, ignorance of diseases, and poor access to the treatment.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.4% (2018-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic (U.S.), Intuitive Surgical Inc. (U.S.), TransEnterix Inc. (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Mediflex Surgical Product (U.S.), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of upper GI diseases
  • Changing lifestyle
  • Increasing demand for minimally invasive surgery


  • Frequently Asked Questions (FAQ) :


    Dumping syndrome market is projected to grow at a 6.4% CAGR between 2017- 2023.

    The Americas is expected to dominate the dumping syndrome market.

    Medical history, gastric emptying test, blood sugar test, and others are the different types of diagnosis for dumping syndrome.

    Certain side effects may limit the dumping syndrome market growth.

    Notable players profiled in the dumping syndrome market include Mediflex Surgical Product (U.S.), Johnson & Johnson Services, Inc. (U.S.), GI Dynamics Inc. (U.S.), Cousin Biotech (France), USGI Medical Inc. (U.S.), ALLERGAN (Republic of Ireland), TransEnterix Inc. (U.S.), Intuitive Surgical Inc. (U.S.), and Medtronic (U.S.).

    Table Of Content

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Dumping Syndrome Market, By Diagnosis

    6.1 Introduction

    6.2 Blood Sugar Test

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Gastric Emptying Test

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Dumping Syndrome Market, By Treatment

    7.1 Introduction

    7.2 Medication

    7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3 Surgery

    7.3.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 8. Global Dumping Syndrome Market, By End User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.2.1 Market Estimates & Forecast, 2020 – 2027

    8.3 Research Laboratories

    8.3.1 Market Estimates & Forecast, 2020 – 2027

    8.4 Others

    Chapter 9. Global Dumping Syndrome Market, By Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 U.K

    9.3.1.6 Rest Of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic Of Korea

    9.4.6 Rest Of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest Of The Middle East & Africa

    Chapter 10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Medtronic

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Intuitive Surgical Inc

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 TransEnterix Inc

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 ALLERGAN

    11.4.1 Company Overview

    11.4.2 Product /Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 USGI Medical Inc

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial Overview

    11.5.4 Key Developments

    11.6 Cousin Biotech

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 GI Dynamics Inc

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs Of The Market

    12.2 Key Companies To Watch

    12.3 Prediction Of Healthcare Industry

    Chapter 13 Appendix

    LIST OF TABLES

    Table 1 Dumping Syndrome Industry Synopsis, 2020 – 2027

    Table 2 Global Dumping Syndrome Market Estimates And Forecast, 2020 – 2027, (USD Million)

    Table 3 Global Dumping Syndrome Market By Region, 2020 – 2027, (USD Million)

    Table 4 Global Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 5 Global Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 6 Global Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 7 North America Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 8 North America Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 9 North America Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 10 US Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 11 US Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 12 US Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 13 Canada Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 14 Canada Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 15 Canada Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 16 South America Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 17 South America Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 18 South America Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 19 Europe Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 20 Europe Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 21 Europe Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 22 Western Europe Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 23 Western Europe Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 24 Western Europe Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 25 Eastern Europe Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 26 Eastern Europe Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 27 Eastern Europe Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 28 Asia Pacific Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 29 Asia Pacific Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 30 Asia Pacific Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    Table 31 Middle East & Africa Dumping Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 32 The Middle East & Africa Dumping Syndrome Market By Treatment, 2020 – 2027, (USD Million)

    Table 33 The Middle East & Africa Dumping Syndrome Market By End Users, 2020 – 2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Global Dumping Syndrome Market

    Figure 3 Segmentation Market Dynamics For Global Dumping Syndrome Market

    Figure 4 Global Dumping Syndrome Market Share, By Diagnosis 2020

    Figure 5 Global Dumping Syndrome Market Share, By Treatment 2020

    Figure 6 Global Dumping Syndrome Market Share, By End Users, 2020

    Figure 7 Global Dumping Syndrome Market Share, By Region, 2020

    Figure 8 North America Dumping Syndrome Market Share, By Country, 2020

    Figure 9 Europe Dumping Syndrome Market Share, By Country, 2020

    Figure 10 Asia Pacific Dumping Syndrome Market Share, By Country, 2020

    Figure 11 Middle East & Africa Dumping Syndrome Market Share, By Country, 2020

    Figure 12 Global Dumping Syndrome Market: Company Share Analysis, 2020 (%)

    Figure 13 Medtronic: Key Financials

    Figure 14 Medtronic: Segmental Revenue

    Figure 15 Medtronic: Geographical Revenue

    Figure 16 Intuitive Surgical Inc.: Key Financials

    Figure 17 Intuitive Surgical Inc.: Segmental Revenue

    Figure 18 Intuitive Surgical Inc.: Geographical Revenue

    Figure 19 TransEnterix Inc.: Key Financials

    Figure 20 TransEnterix Inc.: Segmental Revenue

    Figure 21 TransEnterix Inc.: Geographical Revenue

    Figure 22 ALLERGAN: Key Financials

    Figure 23 ALLERGAN: Segmental Revenue

    Figure 24 ALLERGAN: Geographical Revenue

    Figure 25 USGI Medical Inc.: Key Financials

    Figure 26 USGI Medical Inc: Segmental Revenue

    Figure 27 USGI Medical Inc: Geographical Revenue

    Figure 28 Cousin Biotech..: Key Financials

    Figure 29 Cousin Biotech.: Segmental Revenue

    Figure 30 Cousin Biotech..: Geographical Revenue

    Figure 31 GI Dynamics Inc.: Key Financials

    Figure 32 GI Dynamics Inc.: Segmental Revenue

    Figure 33 GI Dynamics Inc.: Geographical Revenue